Search Results - "Parmar, Nisha V"

Refine Results
  1. 1
  2. 2

    Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs by Al Hammadi, Anwar, Parmar, Nisha V., Aljefri, Khadija, Al Sharif, Osama, Abdallah, Marwa, Ahmed, Haytham Mohamed, Ammoury, Alfred

    Published in Dermatology and therapy (01-07-2023)
    “…Background Alopecia areata (AA) is an autoimmune disease characterized by non-scarring hair loss in adults and children. Clinical manifestations range from…”
    Get full text
    Journal Article
  3. 3

    Prevalence and burden of vitiligo in Africa, the Middle East and Latin America by Al Hammadi, Anwar, Silva de Castro, Caio Cesar, Parmar, Nisha V., Ubogui, Javier, Hatatah, Nael, Ahmed, Haytham Mohamed, Llamado, Lyndon

    Published in Skin health and disease (01-02-2024)
    “…Vitiligo is a common chronic autoimmune disorder characterized by skin and hair depigmentation that affects 0.5%–2.0% of the global population. Vitiligo is…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Successful treatment of dyshidrotic palmoplantar eczema with tralokinumab by Parmar, Nisha V., Hammadi, Anwar Al

    Published in Australasian journal of dermatology (01-09-2024)
    “…Dyshidrotic palmoplantar eczema or pompholyx is considered to be a part of the spectrum of atopic dermatitis with a significant impact on the quality of life…”
    Get full text
    Journal Article
  9. 9

    Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark-Skinned Patients: A Comparative Study by Sarkar, Rashmi, Parmar, Nisha V, Kapoor, Sheilly

    Published in Dermatologic surgery (01-04-2017)
    “…BACKGROUNDFacial postinflammatory hyperpigmentation (PIH) is challenging to manage in patients with skin of color because of the risk of subsequent…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Long‐term real‐world experience of the side effects of dupilumab in 128 patients with atopic dermatitis and related conditions aged 6 years and above: Retrospective chart analysis from a single tertiary care center by Parmar, Nisha V., Abdula, Mohamed Ahmed, Al Falasi, Amani, Krishna, C. Vijay

    Published in Dermatologic therapy (01-05-2022)
    “…Dupilumab is a monoclonal antibody against interleukins 4 and 13 currently FDA approved for the treatment of moderate to severe atopic dermatitis (AD) in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Narrowband Ultraviolet B Phototherapy versus Excimer Laser in the Treatment of Vitiligo: A Retrospective Analysis by Mohamed, Esmaeel Alsayed, Parmar, Nisha V, Falasi, Amani Al

    “…Introduction: Vitiligo is an acquired autoimmune disorder of depigmentation with a global prevalence of 1%. Phototherapy with Narrowband Ultraviolet B (NBUVB)…”
    Get full text
    Journal Article
  20. 20